The medtech startup incubator Ajax Health has launched a new venture for developing pulsed field ablation treatments to zap the common irregular heart rhythm known as atrial fibrillation.
Cortex will start off with $90 million in funding commitments, led by KKR and Hellman & Friedman, with backing from other investors that include AI Life Sciences, an affiliate of Access Industries.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,